Soni
P.1, Nerurkar A.2, Gandhi V.3
1Dr.
Payal Soni, Tutor, 2Dr. Alka Nerurkar, Professor and Head, 3Dr.
Vicky Gandhi, Assistant Professor; all author are affiliated with Microbiology
Department, GMERS Medical College and Hospital, Valsad, Gujarat, India.
Corresponding Author: Dr.
Payal Soni, Tutor, Microbiology Department, GMERS Medical College and Hospital,
Valsad, Gujarat, India. E-mail: drpayalsoni@gmail.com
Abstract
Introduction:
Urinary Tract Infections (UTIs) are amongst the 2nd most common
infections after respiratory tract infections in community and healthcare
settings (Hospital acquired infections). Klebsiella
pneumoniae is the 2nd most common uropathogen after Escherichia coli. Klebsiella is known to have several
virulence factors and resistant strains are rising which includes
Extended-spectrum Beta-lactamase (ESBL) producing and Carbapenem-resistant
strains. Aim of the study is to assess the prevalence of Klebsiella pneumoniae as an Uropathogen and their antimicrobial
susceptibility pattern at a tertiary care hospital, Valsad. Material and Methods: Retrospective
study is conducted including isolates of Klebsiella
pneumoniae from urine samples received in microbiology laboratory at a
tertiary care hospital, Valsad, Gujarat, India from January 2018 to December
2018. Processing of samples, isolation and identification of Klebsiella pneumoniae strains with
Antimicrobial susceptibility testing were done using standard microbiology
techniques. Result: Out of 576 urine
samples received in 2018, 209 (36.28%) showed significant growth. Prevalence of
Klebsiella pneumoniae as Uropathogen
is 9.72% (n=576) and their antimicrobial susceptibility pattern shows higher
resistance to β-lactum group (Penicillin, Cephalosporins and Carbapenem). Susceptibility
is maximum against Chloramphenicol (87.5%) followed by Nitrofurantoin (64.29%),
Amikacin (62.5%), Imipenem (60.71%), Meropenem (60.71%), Levofloxacin (57.14%)
and Piperacillin/Tazobactum (57.14%). Conclusion: Klebsiella pneumoniae remains an important Uropathogen both in
community and Hospital acquired infections. Resistance among Klebsiella
pneumoniae strains shows upward trends over last few years. Increasing
prevalence of ESBL producing and Carbapenem resistant strains creates alarming
situation for healthcare system.
Key
words: Klebsiella pneumoniae, Antimicrobial
susceptibility pattern, Uropathogen
Author Corrected: 25th March 2019 Accepted for Publication: 27th March 2019
Introduction
Klebsiella species
are commensal in human intestines and saprophyte in soil. Klebsiella pneumoniae, an opportunistic pathogen, is responsible
for lobar pneumonia, urinary tract infections, meningitis, septicemia and
pyogenic infections in community and health care settings [1,2]. Urinary Tract
Infections (UTIs) are amongst the 2nd most common infections after
respiratory tract infections in community and healthcare settings (Hospital
acquired infections), which is responsible for increased morbidity and economic
burden to the community. Klebsiella
pneumoniae is the 2nd most common uropathogen after Escherichia coli [3,4].
Capsular
polysaccharides, lipopolysaccharide (LPS) and siderophores are important
virulence factor associated with Klebsiella [5]. K. pneumonia strains can acquire a variety of 𝛽-lactamase
enzymes, which can destroy the chemical structure of 𝛽-lactam
antibiotics such as penicillins, cephalosporins and carbapenems, which are most
widely used antibiotics [6]. Klebsiella
pneumoniae is identified as one of the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae,
Acinetobacter, Pseudomonas aeruginosa and
Enterobacter) pathogens by the Infectious
Diseases Society of America (IDSA) in 2004, which are considered as greatest threat,
due to the emergence of strains that are resistant to all or most available
antibiotics [2,7]. According to Center of Disease Control (CDC),
Extended-spectrum Beta-lactamase (ESBL) producing and Carbapenem-resistant
Enterobacteriaceae (CRE) are considered as serious and urgent threat for the
whole world [8].
Based
on current scenario, it is of prime importance to know about prevalence of Klebsiella pneumoniae and its
antimicrobial susceptibility pattern at local level to deal with it
effectively. Aim of the study is to assess the prevalence of Klebsiella pneumoniae as an Uropathogen
and their antimicrobial susceptibility pattern at a tertiary care hospital,
Valsad.
Material
and Method
Setting:
Tertiary care hospital, Valsad, Gujarat, India
Type of study:
Retrospective study
Study duration:
January 2018 to December 2018
Inclusion criteria:
All samples of urine received in microbiology laboratory in sterile container
which shows growth of Klebsiella pneumoniae.
Exclusion criteria:
All samples of urine which shows growth other than Klebsiella pneumoniae or no growth.
Sample processing:
Cultures of urine samples were done on Blood agar (Semi-quantitative method)
and MacConkey agar. 105 Colony forming unit count is considered as
significant growth. Klebsiella pneumoniae
strains were identified using standard microbiology techniques [9].
Antimicrobial susceptibility testing of Klebsiella
pneumonia strains were performed on Muller Hinton agar using disk diffusion
(modified Kirby-Bauer) method as per Clinical laboratory Standard Institute
guideline 2018[10]. Standard strains used were ATCC E. coli 25922, ATCC S.
aureus 25923 and ATCC P. aeruginosa 27853.
Data
analysis: Data were entered in excel sheet and
analyzed using Microsoft Excel.
Result
Out
of 576 urine samples received in 2018, 209 (36.28%) showed significant growth.
Table-1: Frequency and
percentage positivity of different organisms isolated from urine samples
(n=209)
Sr. No. |
Organism |
Frequency (Out of 209) |
Percentage positivity (%) |
1 |
Escherichia coli |
83 |
39.71 |
2 |
Klebsiella pneumoniae |
56 |
26.79 |
3 |
Enterococcus spp. |
28 |
13.40 |
4 |
Pseudomonas aeruginosa |
14 |
6.70 |
5 |
Acinetobacter spp. |
11 |
5.26 |
6 |
Proteus spp. |
8 |
3.83 |
7 |
Staphylococcus aureus |
5 |
2.39 |
8 |
Other
|
4 |
1.91 |
Table-1
shows Escherichia coli as commonly
isolated organism followed by Klebsiella
pneumoniae and other organisms.
Table-2: Age and sex wise
distribution of Klebsiella pneumoniae
strains (n=56)
Age in years |
Male |
Female |
Total |
1-18 |
6 |
7 |
13 |
18-55 |
8 |
28 |
36 |
>
55 |
5 |
2 |
7 |
Total |
19 |
37 |
56 |
The
chi square statistic is 7.4586. The p-value is 0.024 < 0.05. (Significant
difference)
Table-2
shows age and sex wise distribution of Klebsiella
pneumoniae strains. Age group 18-55 years is more common followed by age
group 1-18 and > 55 years. Females are more affected than male except in age
group >55 years, where males are more affected. This difference is
statistically significant according to chi square test.
Table-3: Location wise
distribution of Klebsiella pneumoniae
strains (n=56)
Location |
No. |
Outdoor
Patient Department (OPD) |
18 |
Indoor
Patients Department (IPD) |
38 |
Table-3
shows location wise distribution which shows higher isolation in indoor
patients.
Figure-1: Antimicrobial susceptibility pattern
(β-lactam group) of Klebsiella pneumoniae
(n=56)
Figure-2: Antimicrobial susceptibility pattern
(Other than β-lactam group) of Klebsiella pneumoniae (n=56)
Figure-1
and 2 shows antimicrobial susceptibility pattern of Klebsiella pneumoniae strains. Susceptibility to Chloramphenicol is
85.5% followed by Nitrofurantoin (64.29%), Amikacin (62.5%), Imipenem (60.71%)
and Meropenem (60.71%), Piperacillin-Tazobactum (57.14%) and Levofloxacin
(57.14%). Cephalosporins shows higher resistance.
Figure-3: Comparison of %
susceptibility of OPD (n=18), IPD (n=38) and Total (n=56) isolates (β-lactam
group)
Figure-4: Comparison of %
susceptibility of OPD (n=18), IPD (n=38) and Total (n=56) isolates (Other than
β-lactam group)
Figure-3 and 4 show
comparison between susceptibility of OPD, IPD and Total strains. OPD strains
show good susceptibility to antimicrobial agent as compare to IPD strains.
Discussion
Prevalence
of Klebsiella pneumonie as
Uropathogen is 9.72% (n=576) and their antimicrobial susceptibility pattern
shows higher resistance to β-lactam group (Penicillin, Cephalosporins and
Carbapenem). Susceptibility is maximum against Chloramphenicol (87.5%) followed
by Nitrofurantoin (64.29%), Amikacin (62.5%), Imipenem (60.71%), Meropenem
(60.71%), Levofloxacin (57.14%) and Piperacillin/Tazobactum (57.14%).
Table:
1 shows frequency of different organisms isolated from urine samples. Escherichia coli(39.71%) is commonly
isolated bacteria which is comparable with similar study conducted by Vicky
Gandhi et al [11]which shows 36.75% and Harshkumar B. Patel et al [12]. which
shows 36.11% prevalence of the same, followed by Klebsiella pneumoniae (26.79%) which is higher as compare to
similar study conducted in Gujarat by Vicky Gandhi et al [11] which shows
18.21%, Harshkumar B. Patel et al.[12]
which shows 18.06%, Parevee Dalalet al [13]. which shows 14.22%, Disha
Sharma et al [14]. Which shows 9.04% and
Nilofar R. Sodagar et al [15]. which shows
18.3% prevalence of Klebsiella
pneumoniae. Table: 3 shows location wise distribution of Klebsiella pneumoniae strains. Increased
prevalence of Klebsiella pneumonia in
Indoor patients may suggest increasing nosocomial infection which creates
alarming situation.
Table:
2 shows age and sex wise distribution, which is statistically significant (p
value: 0.024). Higher prevalence in
sexually active females of 18-55 years age group is because of shorter urethra,
proximity of urethral meatus to anus and reinfection [1]. In male of age group
>55 years, prevalence is high due to age related prostatic enlargement which
interferes with emptying of bladder [1].
Figure:
1 and 2 shows Antimicrobial Susceptibility pattern of Klebsiella pneumoniaeagainst different antimicrobial agents. 42.86%
were ESBL producer. 39.29% strains were resistant to Carbapenem. Susceptibility
pattern is comparable with similar study conducted in Ahmedabad, Gujarat by
Harshkumar et al [12] and Parevee Dalal et al [13].
In
present study, Susceptibility to Imipenem (60.71%), Levofloxacin (57.14%) and
Cephalosporins (10-30%) is lower as compare to similar study conducted in
Valsad by Niraj kumar Biswas et al [16] in 2014 (Imipenem 91.82%, Levofloxacin
66.70% and Cephalosporins 40-60%) and Vicky Gandhi et al [11] in 2016 (Imipenem
87%, Levofloxacin 60% and Cephalosporins 20-40%). Study conducted by Shankar
Srinivasan et al [17] in 2014 at Mumbai shows Susceptibility of 89-90% for
Carbapenems and Levofloxacin. Susceptibility to Nitrofurantoin is 64.29% which
is comparable with study conducted at Udaipur by Ritu Bhatnagar et al [18]
(68.57%).
This
scenario suggests growing resistance among bacterial strains against commonly
used flouroquinolones and cephalosporins as well as last resort drug,
carbapenems. Resistances against
commonly used antimicrobials create selective pressure on last resort drug.
Selective pressure along with over the counter drugs, lack of regulations and
unnecessary uses of antimicrobials are important factors responsible for
increased resistance in developing country like India [19].
Change
in susceptibility pattern suggests increasing trend of resistance among Klebsiella strains. Antimicrobial policy
should be made according to the susceptibility pattern. Hospital infection
control measures should be followed stringently to control this situation.
Klebsiella pneumoniae
is important nosocomial infections with higher chances of infection in
immunocompromised patients, patients on mechanical ventilation, intravenous
catheters, urinary catheters or on long course of immunosuppressant drugs [20].
Figure: 3 and 4 shows Comparison of % Susceptibility of OPD (n=18), IPD (n=38)
and Total (n=56) isolates against different antimicrobial agents. Strains
isolated from OPD patients shows higher Susceptibility even to Cephalosporins
as compare to strains isolated from IPD strains. This may suggests increasing
prevalence of nosocomial infections by resistant strains. Community acquired
strains still have good Susceptibility against commonly used antimicrobials.
Nitrofurantoin, an age old oral drug, can be used as an alternative for OPD patients.
Klebsiella pneumonie
can acquire resistance against Carbapenem and other antimicrobial by various
mechanisms which includes enzymatic inactivation, target site modification,
efflux pump etc. Carbapenamase enzymes have significant impact on usages of
antimicrobials in gram negative infections. These resistances are plasmid coded
and can be transferred to other bacteria also, which increases chance of
resistance among other bacteria in health care settings [21].
Further
classification of Carbapenem resistant Klebsiella
pneumoniae strains can be done based on Ambler classification [22].
Phenotypic and Molecular methods can detect different enzyme and its
corresponding genes, which can help to evaluate prevalent resistant strains.
Due to lack of testing facility at present study setup, it remains limitation
for this study.
Conclusion
In
community and Hospital acquired infections,
Klebsiella pneumoniae remains an important Uropathogen. Resistance among Klebsiella pneumoniae strains shows
upward trends over last few years. Increasing prevalence of ESBL producing and
Carbapenem resistant strains creates alarming situation for healthcare system.
Phenotypic and Molecular level gene analysis should be done to identify
prevalence of resistant strains. Active surveillance system and stringent
hospital infection control measures should be implemented to control further
rise.
This
study provides prevalence and Antimicrobial susceptibility pattern of Klebsiella pneumoniae as Uropathogen at
local level to create antibiogram for Hospital infection control policy to deal
with it effectively.
Contribution of authors: Bacterial
identification and reporting of all samples were done by Dr. PayalSoni and Dr.
Vicky Gandhi under the guidance of Dr. Alka Nerurkar. All authors have contributed
in manuscript writing.
References: